Expression of concern
Recombinant adeno‐associated virus (rAAV) expressing TFPI‐2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line
Paper Information
Record ID:
26940
Author(s):
Journal:
Publication Date:
February 18, 2005
Retraction Date:
February 26, 2021
(4.7 years years ago)
Subjects:
Institutions:
- Program of Cancer Biology, Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine, Peoria, IL, USA
- Department of Pathology, University of Illinois College of Medicine, Peoria, IL, USA
- Department of Neurosurgery, University of Illinois College of Medicine, Peoria, IL, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Citations (64)
64
Total Citations8
Post-Retraction(12.5%)
56
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
5
After 2+ years
1556
Days since retraction (latest)
Oncolytic virotherapy offers hope for high-grade glioma treatment
Liping He, Fang Wang, Jun Liu et al. (4 authors)
Cell investigation.
Open Access
Published: Jun 2025
1556 days after retraction
Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications
Henri H. Versteeg, Jeroen T. Buijs, Maaike Y. Kapteijn et al. (5 authors)
Thrombosis and Haemostasis
Open Access
Published: Aug 2024
3 citations
3 citations
1272 days after retraction
Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis
Marek Z. Wojtukiewicz, M. Myśliwiec, Anna Tokajuk et al. (9 authors)
Cancer and Metastasis Reviews
Open Access
Published: Aug 2024
3 citations
3 citations
1268 days after retraction
Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers
Hiroshi Kobayashi, Shogo Imanaka, Sho Matsubara et al. (5 authors)
International Journal of Translational Medicine
Open Access
Published: Jun 2024
2 citations
2 citations
1218 days after retraction
Cell and gene therapy in neuro-oncology
María L. Varela, Andrea Comba, Syed Mohd Faisal et al. (8 authors)
Handbook of clinical neurology
Published: Jan 2024
1039 days after retraction
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate
Aline Ramos Maia Lobba, Miryam Paola Alvarez‐Flores, Melissa Regina Fessel et al. (10 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Aug 2022
4 citations
4 citations
536 days after retraction
Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor
Marion Lavergne, Audrey Guillon‐Munos, Woodys Lenga Ma Bonda et al. (12 authors)
Biological Chemistry
Published: May 2021
11 citations
11 citations
75 days after retraction
Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy
Marek Z. Wojtukiewicz, M. Myśliwiec, Elwira Matuszewska et al. (9 authors)
Biomolecules
Open Access
Published: Apr 2021
17 citations
17 citations
62 days after retraction
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Xin Xu, Wenli Chen, Wenjun Zhu et al. (10 authors)
Cancer Cell International
Open Access
Published: Jan 2021
30 citations
30 citations
31 days before retraction
Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1
Wenzheng Luo, Xueyuan Li, Zhenyu Song et al. (5 authors)
Aging
Open Access
Published: Jun 2019
57 citations
57 citations
626 days before retraction
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
Ningbo Xu, Boyang Liu, Changlin Lian et al. (12 authors)
Cell Death and Disease
Open Access
Published: Nov 2018
70 citations
70 citations
834 days before retraction
Adeno-associated virus (AAV) vectors in cancer gene therapy
Jorge L. Santiago-Ortiz, David V. Schaffer
Journal of Controlled Release
Open Access
Published: Jan 2016
195 citations
195 citations
1871 days before retraction
Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy
Fengkai Sun, Qi Sun, Yu‐Chen Fan et al. (12 authors)
Journal of Gastroenterology and Hepatology
Open Access
Published: Aug 2015
26 citations
26 citations
2010 days before retraction
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
Carmen Ghilardi, Antonietta Rosa Silini, Sara Figini et al. (8 authors)
Oncotarget
Open Access
Published: Jul 2015
17 citations
17 citations
2046 days before retraction
Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.
Lulu Zhai, Yang Wu, Dawei Huang et al. (4 authors)
PubMed
Published: Jan 2015
23 citations
23 citations
2248 days before retraction
Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma
Yi-Hui Lai, Ru-Yin He, Jian‐Liang Chou et al. (6 authors)
Journal of Translational Medicine
Open Access
Published: Sep 2014
24 citations
24 citations
2370 days before retraction
The role of tissue factor isoforms in cancer biology
Ulrike Leppert, Andreas Eisenreich
International Journal of Cancer
Open Access
Published: May 2014
37 citations
37 citations
2486 days before retraction
Expression of tissue factor pathway inhibitor-2 in gastric stromal tumor and its clinical significance
Guijun Wang, Yubin Wang, Dinuo Li et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Dec 2013
7 citations
7 citations
2632 days before retraction
Secretome-Based Identification of TFPI2, A Novel Serum Biomarker for Detection of Ovarian Clear Cell Adenocarcinoma
Noriaki Arakawa, Etsuko Miyagi, Ayako Nomura et al. (9 authors)
Journal of Proteome Research
Published: Jun 2013
78 citations
78 citations
2800 days before retraction
Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
Feng-Kai SunYu-Chen, FanJing Zhao, Feng ZhangShuai et al. (4 authors)
Unknown Journal
Published: Jan 2013
2978 days before retraction
Epigenetic dysregulation of novel candidate genes in melanoma
Hexiao Wang
Unknown Journal
Published: Jan 2013
2978 days before retraction
Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
Fengkai Sun, Yu‐Chen Fan, Jing Zhao et al. (8 authors)
Digestive Diseases and Sciences
Published: Oct 2012
62 citations
62 citations
3041 days before retraction
Anti-angiogenic gene therapy in the treatment of malignant gliomas
Na Tosha Gatson, E. Antonio Chiocca, Balveen Kaur
Neuroscience Letters
Open Access
Published: Aug 2012
57 citations
57 citations
3122 days before retraction
Actions of the Kunitz-type serine protease inhibitor Amblyomin-X on VEGF-A-induced angiogenesis
Carine Cristiane Drewes, R.Y.S. Dias, Cristina Bichels Hebeda et al. (8 authors)
Toxicon
Open Access
Published: May 2012
35 citations
35 citations
3217 days before retraction
Tissue Factor Pathway Inhibitor-2 Inhibits the Growth and Invasion of Hepatocellular Carcinoma Cells and is Inactivated in Human Hepatocellular Carcinoma
Yong Xu, Xiaolin Qin, Jinjing Zhou et al. (8 authors)
InTech eBooks
Open Access
Published: Feb 2012
11 citations
11 citations
3304 days before retraction
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer
Qiao Zhang, Yao Zhang, Shi Z Wang et al. (7 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jan 2012
150 citations
150 citations
3343 days before retraction
The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells
Chundi Xu, Feng’e Deng, Zuohua Mao et al. (9 authors)
Biochemical Journal
Published: Sep 2011
12 citations
12 citations
3440 days before retraction
Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma
Yong Xu
Oncology Letters
Open Access
Published: Jul 2011
18 citations
18 citations
3524 days before retraction
Paper citing Recombinant adeno‐associated virus (rAAV) expressi...
Unknown Authors
Unknown Journal
Published: Jul 2011
3524 days before retraction
Knockdown of TFPI-2 promotes migration and invasion of glioma cells
Florian Geßler, Valerie Voss, Volker Seifert et al. (5 authors)
Neuroscience Letters
Published: Apr 2011
44 citations
44 citations
3598 days before retraction
Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma
Erik H.P. van Putten, Clemens MF Dirven, Martin J. van den Bent et al. (4 authors)
Future Oncology
Published: Dec 2010
30 citations
30 citations
3732 days before retraction
Epigenetic Upregulation of Urokinase Plasminogen Activator Promotes the Tropism of Mesenchymal Stem Cells for Tumor Cells
Sai Murali Krishna Pulukuri, Bharathi Gorantla, Venkata Ramesh Dasari et al. (5 authors)
Molecular Cancer Research
Open Access
Published: Jul 2010
31 citations
31 citations
3866 days before retraction
Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Teodora Ribarska, Marc Ingenwerth, Wolfgang Goering et al. (5 authors)
PubMed
Published: Mar 2010
51 citations
51 citations
3990 days before retraction
Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer
Hisashi Takada, Naoki Wakabayashi, Osamu Dohi et al. (8 authors)
Cancer Genetics and Cytogenetics
Published: Jan 2010
75 citations
75 citations
4048 days before retraction
Paper citing Recombinant adeno‐associated virus (rAAV) expressi...
Unknown Authors
Unknown Journal
Published: Dec 2009
4105 days before retraction
Human tissue factor pathway inhibitor-2 suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.
Jing Yuan, Yu Jian-xiong
PubMed
Published: Nov 2009
5 citations
5 citations
4124 days before retraction
Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis
Zhi‐Gang Tang, Guangyong Geng, Qiang Huang et al. (7 authors)
Medical Oncology
Published: Sep 2009
17 citations
17 citations
4188 days before retraction
Expression of Tissue Factor Pathway Inhibitor 2 in Human Pancreatic Carcinoma and its Effect on Tumor Growth, Invasion, and Migration In Vitro and In Vivo
Zhi‐Gang Tang, Guangyong Geng, Qiang Huang et al. (7 authors)
Journal of Surgical Research
Published: Jul 2009
25 citations
25 citations
4244 days before retraction
Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside
Isabelle M. Germano, Emanuela Binello
Journal of Neuro-Oncology
Published: May 2009
36 citations
36 citations
4319 days before retraction
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
Sophie Iochmann, Claire Bléchet, Valérie Chabot et al. (8 authors)
Clinical & Experimental Metastasis
Published: Mar 2009
42 citations
42 citations
4374 days before retraction
EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression
Ding
Oncology Reports
Open Access
Published: Feb 2009
57 citations
57 citations
4398 days before retraction
Tissue Factor Pathway Inhibitor: Structure and Function
Hisao Kato
Springer eBooks
Published: Jan 2009
2 citations
2 citations
4426 days before retraction
Gene Therapy for Brain Tumors
Martine L.M. Lamfers, E. Antonio Chiocca
Springer eBooks
Published: Jan 2009
1 citation
1 citation
4439 days before retraction
A Novel Role for Tissue Factor Pathway Inhibitor-2 in the Therapy of Human Esophageal Carcinoma
Yuliang Ran, Jian Pan, Hai Hu et al. (10 authors)
Human Gene Therapy
Published: Jan 2009
31 citations
31 citations
4439 days before retraction
The Role of Thrombin in Angiogenesis
Nikos E. Tsopanoglou, Michael E. Maragoudakis
Springer eBooks
Published: Oct 2008
6 citations
6 citations
4519 days before retraction
Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line
Prakasha Kempaiah, Walter Kisiel
APOPTOSIS
Published: Apr 2008
28 citations
28 citations
4706 days before retraction
Paper citing Suppression of matrix metalloproteinase-2 gene exp...
Unknown Authors
Unknown Journal
Published: Apr 2008
4714 days before retraction
The Role of the Adeno-Associated Virus Capsid in Gene Transfer
Kim Van Vliet, Véronique Blouin, Nicole Brument et al. (5 authors)
Methods in molecular biology
Open Access
Published: Jan 2008
112 citations
112 citations
4805 days before retraction
ADAMTS1 i TFPI-2: Estudi de la seva interacció funcional i les implicacions en la plasticitat tumoral.
Torres Collado, A.E. Xavier
TDX (Tesis Doctorals en Xarxa)
Published: Dec 2007
4817 days before retraction
The Role of Tissue Factor Pathway Inhibitor-2 in Cancer Biology
Ewa Sierko, Marek Z. Wojtukiewicz, Walter Kisiel
Seminars in Thrombosis and Hemostasis
Published: Oct 2007
102 citations
102 citations
4897 days before retraction
Quick Stats
Total Citations:
64
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025